X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (25) 25
humans (24) 24
multiple sclerosis (22) 22
female (20) 20
clinical neurology (19) 19
male (17) 17
middle aged (17) 17
adult (15) 15
neurosciences (11) 11
adolescent (8) 8
disease progression (7) 7
multiple sclerosis - physiopathology (7) 7
cross-sectional studies (6) 6
multiple sclerosis - complications (6) 6
risk factors (6) 6
aged (5) 5
disability evaluation (5) 5
neurology (5) 5
pregnancy (5) 5
prevalence (5) 5
treatment outcome (5) 5
young adult (5) 5
age of onset (4) 4
aged, 80 and over (4) 4
care and treatment (4) 4
development and progression (4) 4
double-blind (4) 4
fatigue (4) 4
multiple sclerosis - epidemiology (4) 4
multiple sclerosis - psychology (4) 4
proportional hazards models (4) 4
risk (4) 4
severity of illness index (4) 4
age (3) 3
analysis (3) 3
belgium (3) 3
belgium - epidemiology (3) 3
biochemistry & molecular biology (3) 3
cognition disorders - etiology (3) 3
data processing (3) 3
disability progression (3) 3
double-blind method (3) 3
immunomodulation (3) 3
multiple sclerosis, relapsing-remitting - diagnosis (3) 3
multiple sclerosis, relapsing-remitting - physiopathology (3) 3
natural-history (3) 3
progression (3) 3
quality-of-life (3) 3
rehabilitation (3) 3
reproducibility of results (3) 3
sex factors (3) 3
time factors (3) 3
administration, oral (2) 2
animals (2) 2
birth (2) 2
cancer (2) 2
cell biology (2) 2
cigarette-smoking (2) 2
cognition disorders - diagnosis (2) 2
complications and side effects (2) 2
controlled trial (2) 2
disability (2) 2
disease (2) 2
education (2) 2
epidemiology (2) 2
europe (2) 2
european union (2) 2
expression (2) 2
family (2) 2
fatigue - etiology (2) 2
fatigue - physiopathology (2) 2
follow-up (2) 2
genomics (2) 2
glatiramer acetate (2) 2
health (2) 2
health aspects (2) 2
health surveys (2) 2
immunosuppressive agents - adverse effects (2) 2
impact scale (2) 2
integration (2) 2
kaplan-meier estimate (2) 2
medicine & public health (2) 2
menarche (2) 2
mouse (2) 2
multiple sclerosis - drug therapy (2) 2
multiple sclerosis - genetics (2) 2
multiple sclerosis - therapy (2) 2
multiple sclerosis, chronic progressive - complications (2) 2
multiple sclerosis, chronic progressive - diagnosis (2) 2
multiple sclerosis, relapsing-remitting - complications (2) 2
multiple sclerosis, relapsing-remitting - drug therapy (2) 2
multiple-sclerosis (2) 2
mutation (2) 2
national identity (2) 2
neuropsychological tests (2) 2
neuroradiology (2) 2
onset (2) 2
oral contraceptives (2) 2
origin (2) 2
pasat (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Neurorehabilitation and Neural Repair, ISSN 1545-9683, 01/2008, Volume 22, Issue 1, pp. 91 - 100
Fatigue is one of the most common and most disabling symptoms of multiple sclerosis (MS). Although numerous studies have tried to reveal it, no definite... 
Origin | Fatigue | Multiple sclerosis | Pathophysiology | Primary fatigue | Secondary fatigue | Complications and side effects | Care and treatment | Development and progression | Research | Risk factors
Journal Article
Journal of Neurology, Neurosurgery and Psychiatry, ISSN 0022-3050, 2010, Volume 81, Issue 1, pp. 38 - 41
Journal Article
Journal of Neurology, Neurosurgery and Psychiatry, ISSN 0022-3050, 2010, Volume 81, Issue 1, pp. 38 - 41
Background: The uncertainty about long-term effects of childbirth presents MS patients with dilemmas. Methods: Based on clinical data of 330 female MS... 
Journal Article
Clinical Neurophysiology, ISSN 1388-2457, 2014, Volume 125, pp. S61 - S62
Journal Article
Journal of Neurology, ISSN 0340-5354, 10/2008, Volume 255, Issue 10, pp. 1449 - 1463
This review updates and extends earlier Consensus Reports related to current basic and escalating immunomodulatory treatments in multiple sclerosis (MS). The... 
Multiple Sclerosis | Neurology | randomized trials | Neurosciences | Medicine & Public Health | glatirameracetate | treatment escalation | interferon β | immunotherapy | Neuroradiology | monoclonal antibodies | Treatment escalation | Glatirameracetate | Interferon β | Multiple sclerosis | Randomized trials | Immunotherapy | Monoclonal antibodies | interferon beta | EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS | NEUTRALIZING ANTIBODIES | CLINICAL NEUROLOGY | 1ST DEMYELINATING EVENT | GLATIRAMER ACETATE COPAXONE(R) | INTERFERON-BETA THERAPY | DOUBLE-BLIND | INTRAVENOUS IMMUNOGLOBULIN TREATMENT | PLACEBO-CONTROLLED TRIAL | CLINICALLY ISOLATED SYNDROMES | MITOXANTRONE-INDUCED CARDIOTOXICITY | Azathioprine - therapeutic use | Multiple Sclerosis - diagnosis | Natalizumab | Humans | Antibodies, Monoclonal - adverse effects | Health Planning Guidelines | Glatiramer Acetate | Antibodies, Monoclonal - therapeutic use | Interferon-beta - therapeutic use | Antibodies, Monoclonal, Humanized | Societies - standards | Mitoxantrone - therapeutic use | Antibodies, Monoclonal - pharmacology | Europe | Immunologic Factors - administration & dosage | Azathioprine - pharmacology | Immunoglobulins, Intravenous - pharmacology | Multiple Sclerosis - therapy | Peptides - pharmacology | Plasmapheresis | Randomized Controlled Trials as Topic | Magnetic Resonance Imaging | Immunoglobulins, Intravenous - therapeutic use | Interferon-beta - pharmacology | Mitoxantrone - pharmacology | Peptides - therapeutic use | Immunologic Factors - therapeutic use | Care and treatment | Health aspects | Patient outcomes | Index Medicus
Journal Article
by Lavie, Caroline and Rollot, Fabien and Durand-Dubief, Françoise and Marignier, Romain and Ionescu, Iuliana and Casey, Romain and Moreau, Thibault and Tourniaire, Patricia and Hutchinson, Michael and D’Hooghe, Marie Béatrice and Laplaud, David-Axel and Clavelou, Pierre and De Sèze, Jérôme and Debouverie, Marc and Brassat, David and Pelletier, Jean and Lebrun-Frenay, Christine and Le Page, Emmanuelle and Castelnovo, Giovanni and Berger, Eric and Hautecoeur, Patrick and Heinzlef, Olivier and Durelli, Luca and Clerico, Marinella and Trojano, Maria and Patti, Francesco and Vukusic, Sandra and Alpérovitch, A and Carton, H and d’Hooghe, M.B and Hommes, O and Hutchinson, M and Adeleine, P and Biron, A and Cortinovis-Tourniaire, P and Grimaud, J and Hours, M and Moreau, T and Vukusic, S and Confavreux, C and Chauplannaz, G and Latombe, D and Clanet, M and Lau, G and Rumbach, L and Goas, J.Y and Rouhart, F and Mazingue, A and Roullet, E and Madigand, M and Hautecoeur, P and Brunet, P and Edan, G and Allaire, C and Riffault, G and Leche, J and Benoit, T and Simonin, C and Ziegler, F and Baron, J.C and Rivrain, Y and Dumas, R and Loche, D and Bourrin, J.C and Huttin, B and Delisse, B and Gibert, I and Boulay, C and Verceletto, M and Durand, G and Bonneviot, G and Gil, R and Hedreville, M.A and Belair, C and Poitevin, R.J and Devoize, J.L and Wyremblewski, P and Delestre, F and Setiey, A and Comi, G and Filippi, M and Ghezzi, A and Martinelli, V and Rossi, P and Zaffaroni, M and Tola, M.R and Amato, M.P and Fioretti, C and Meucci, G and Inglese, M and Mancardi, G.L and Gambi, D and Thomas, A and Cavazzuti, M and Citterio, A and Heltberg, A and Hansen, H.J and Fernandez, O and Romero, F and Arbizu, T and ... and PRIMS Investigator and POPARTMUS Investigator and PRIMS and POPARTMUS investigators
Multiple Sclerosis Journal, ISSN 1352-4585, 4/2019, Volume 25, Issue 4, pp. 591 - 600
Background: Obstetrical analgesia remains a matter of controversy because of the fear of neurotoxicity of local anesthetics on demyelinated fibers or their... 
neuraxial analgesia | post-partum | Multiple sclerosis | relapses | pregnancy | GUIDELINES | INTERFERON-BETA EXPOSURE | NEUROSCIENCES | CLINICAL NEUROLOGY | WOMEN | ANESTHESIA | MULTIPLE-SCLEROSIS | PREDICTORS | DIAGNOSTIC-CRITERIA | Pregnancy | Analgesia | Neurotoxicity | Pain perception | Progestin | Data processing | Anesthetics | Estradiol | Local anesthetics | Life Sciences | Santé publique et épidémiologie
Journal Article